AAAAAA
Results:
1-12
|
Results: 12
Authors:
MICHALLET M
THIEBAUT A
Citation: M. Michallet et A. Thiebaut, CHEMOTHERAPY, INTERFERON AND GROWTH-FACTORS IN THE SELECTION OF NEGATIVE PHILADELPHIA CELLS, HEM CELL TH, 40(5), 1998, pp. 241-246
Authors:
THOMAS X
THIEBAUT A
OLTEANU N
DANAILA C
CHARRIN C
ARCHIMBAUD E
FIERE D
Citation: X. Thomas et al., PHILADELPHIA-CHROMOSOME-POSITIVE ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA -CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOME, HEM CELL TH, 40(3), 1998, pp. 119-128
Authors:
THIEBAUT A
MICHALLET M
GEBUHRER L
LASNE Y
CHARRIN C
MOLLET I
BELHABRI A
ARCHIMBAUD E
Citation: A. Thiebaut et al., DONOR LYMPHOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESULTS, Bone marrow transplantation, 21, 1998, pp. 233-233
Authors:
BELHABRI A
MICHALLET M
THIEBAUT A
PHILIP I
CHARRIN C
FIERE D
ARCHIMBAUD E
Citation: A. Belhabri et al., AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOCYTIC-LEUKEMIA (CML) WITH PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) MOBILIZED BY G-CSF (FILGRASTIM) AND INTERFERON-ALPHA (IFN), Bone marrow transplantation, 21, 1998, pp. 292-292
Authors:
THOMAS X
ANGLARET B
CAMPOS L
THIEBAUT A
SABIDO O
BAILLY M
ARCHIMBAUD E
Citation: X. Thomas et al., EXPRESSION OF BETA-1-INTEGRINS AND PSEUDO-IMMUNOGLOBULINS ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS AND ITS MODIFICATIONS DURING IN-VITRO DIFFERENTIATION, Leukemia research, 22(1), 1998, pp. 61-68
Authors:
THIEBAUT A
MICHALLET M
GEBUHRER L
LASNE Y
CHARRIN C
MOLLET I
BELHABRI A
ARCHIMBAUD E
Citation: A. Thiebaut et al., DONOR LYMPHOCYTE INFUSIONS (DLI) FOR RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) - HEMATOLOGIC, CYTOGENETIC AND MOLECULAR RESULTS, British Journal of Haematology, 102(1), 1998, pp. 322-322
Authors:
THOMAS X
ANGLARET B
THIEBAUT A
BELHABRI A
TREILLERITOUET D
FIERE D
ARCHIMBAUD E
Citation: X. Thomas et al., IMPROVEMENT OF PROGNOSIS IN REFRACTORY AND RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA OVER RECENT YEARS - THE ROLE OF ALL-TRANS-RETINOIC ACID THERAPY, Annals of hematology, 75(5-6), 1997, pp. 195-200
Authors:
HAYETTE S
THOMAS X
BERTRAND Y
TIGAUD I
CALLANAN M
THIEBAUT A
CHARRIN C
ARCHIMBAUD E
MAGAUD JP
RIMOKH R
Citation: S. Hayette et al., MOLECULAR ANALYSIS OF CYCLIN-DEPENDENT KINASE INHIBITORS IN HUMAN LEUKEMIAS, Leukemia, 11(10), 1997, pp. 1696-1699
Authors:
THOMAS X
THIEBAUT A
OLTEANU N
CHARRIN C
ARCHIMBAUD E
FIERE D
Citation: X. Thomas et al., PHILADELPHIA-CHROMOSOME-POSITIVE (PH-LEUKEMIA (ALL) - CLINICAL AND CYTOGENETIC CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOME() ADULT ACUTE LYMPHOBLASTIC), Blood, 90(10), 1997, pp. 3793-3793
Authors:
THIEBAUT A
ANGLARET B
THOMAS X
LE QH
CHABERT C
BELHABRI A
FIERE D
ARCHIMBAUD E
Citation: A. Thiebaut et al., IMPACT OF PREINDUCTION THERAPY LEUKAPHERESIS ON TREATMENT OUTCOME IN ADULT ACUTE MYELOGENOUS LEUKEMIA (AML) PRESENTING WITH HYPERLEUKOCYTOSIS, Blood, 90(10), 1997, pp. 3851-3851
Authors:
THIEBAUT A
SEBBAN C
VERNANT JP
THOMAS X
FIERE D
Citation: A. Thiebaut et al., INITIAL CENTRAL-NERVOUS-SYSTEM (CNS) INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - CHARACTERISTICS AND LONG-TERM OUTCOME, Blood, 88(10), 1996, pp. 1479-1479
Authors:
ANGLARET B
THIEBAUT A
THOMAS X
MICHALLET M
FIERE D
ARCHIMBAUD E
Citation: B. Anglaret et al., EFFECT OF CONTINUOUS INTRAVENOUS-INFUSION OF PENTOXIFYLLINE ON REGIMEN RELATED TOXICITY IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 23(8), 1995, pp. 853-853
Risultati:
1-12
|